Price $41.59 |
Market Cap
11.17B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
4.58
|
P/S
3.5
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
20.4
|
Op. Cash Flow
667.1K
|
FCF
2.0
|
|
Op. Margin
-8.50%
|
Net Margin
-2.50%
|
ROE
-2.90%
|
ROI
14.50%
|
|
ROA
-1.00%
|
EPS Growth
-110.30%
|
Current Ratio
0.8
|
Debt/Equity
78.80%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Digirad Corporation (DRAD) | $1.36 | - | 14.70% | 31.2M | Strong Buy |
| Assertio Therapeutics Inc (ASRT) | $5.92 | - | - | 371.4M | Strong Buy |
| Endo International PLC (ENDP) | $17.05 | - | - | 3.62B | Strong Buy |
| Procyon Corp (PCYN) | $0.26 | - | - | 2.3M | Strong Buy |
| Neurometrix Inc (NURO) | $1.26 | - | - | 9.9M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
